Which predicts the cardiovascular risk best in elderly metabolic syndrome patients: ATP III or IDF?


AYDIN S., Gemalmaz A., Nayir T., Ozkan S.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.41, no.1, pp.125-129, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.3906/sag-0912-496
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.125-129
  • Süleyman Demirel University Affiliated: Yes

Abstract

Aim: As metabolic syndrome (MetS) is one of the major determinants of cardiovascular disease, it is important to detect and intervene with MetS in order to minimize cardiovascular risk. The objectives of this study were to identify the prevalence of MetS in our elderly patients and to evaluate the ability IDF and ATP III to predict the cardiovascular risk.